Croatia KG consumption is the latest additions to the Pharma14 platform.

Pharmaceutical expenditure in Croatia accounted for approximately 35% of healthcare or 2.5% of GDP in 2019. Total drug expenditure in Croatia in 2019 was around $1.5 billion, which represents a 10% increase over 2018. Croatia’s pharmaceutical per capita costs are $375, the sixths highest per capita expenditure in the Central and Eastern Europe (CEE) Region.
Prescription drugs account for 90% of all pharmaceutical sales.
The Croatian pharmaceutical market is highly competitive, with market share distributed among a large group of multinational and domestic companies.
The domestic drug industry currently meets 35% of local demand in terms of value and 50% in terms of volume. 

Pharma14 Sample Adalimumab, Infliximab, Vedolizumabe 2019 and 2018 consumption information:

Croatia medicine consumption


14 Shenkar st.


Israel, 46725



Drug Price